Q1 FY27 earnings call · July 31, 2026

Syrma SGS Technology Ltd Q1 FY27 Earnings Call: Guides 30-35% Revenue Growth, Order Book Crosses Rs. 6,770 Cr

Cofacto ResearchPublished July 31, 20267 min read
Quick summary

Syrma SGS Technology Ltd held its Q1 FY27 earnings call on July 29, 2026. Here's a quick read of what management said — performance, strategy, and the outlook ahead.

Headline Numbers

  • Revenue of Rs.1,604 crores — Q1 FY 2026-2027 consolidated revenue grew 67% YoY, with operating EBITDA up 69% to Rs.162 crores and PAT rising 112% to Rs.106 crores.
  • ODM revenue surged ~100% YoY — reached Rs.270 crores in Q1 FY 2026-2027 (from Rs.125 crores in Q1 FY 2025-2026), following 82% growth in FY 2025-2026 to Rs.825 crores.
  • Export revenue of Rs.387 crores — grew 61% YoY and represented 24% of total revenue in Q1 FY 2026-2027; geography mix: USA 22%, Europe 40%, balance other countries.
  • EBITDA margin of 10.1% — Q1 FY 2026-2027 margin was impacted by a higher consumer segment share of 34% vs. management's annualised target of ~30%.
  • Adjusted annualised ROCE of 20.1% — net cash position maintained at Rs.122 crores, with cash and investments exceeding Rs.800 crores.
  • Net working capital days widened to 71 — from 63 in the prior quarter, driven by strategic inventory build amid supply chain constraints.

Pipeline and Customer Growth

  • Order book of Rs.6,770 crores — as of Q1 FY 2026-2027 end, up from Rs.6,400 crores at Q4 FY 2025-2026, implying order intake of Rs.1,781 crores in the quarter; Rs.5,400 crores executable in the next 12 months.
  • 18 new customers onboarded — in Q1 FY 2026-2027, comprising auto (5), industrial (3), healthcare (2), and the balance in telecom, IT, and railways; expected to contribute from FY 2027-2028 with full ramp-up by FY 2028-2029.
  • New customers carry Rs.1,000+ crore potential — management estimates these 18 clients can generate incremental revenue of over Rs.1,000 crores on a full ramp-up basis, with margin profiles aligned to respective verticals.
  • Global wallet-share expansion over 5-7 years — management expects wallet share with global customers to slowly increase from 1-2% to 4-6%, noting that even a 2-4% share can represent a $50-100 million business.
  • Order book composition — automotive 29%, consumer 30%, industrial 24%, healthcare 7%, IT/railways 9%; average execution period of 10-10.5 months.
  • Domestic vs. export mix — current revenue split is approximately 75% domestic and 25% exports; for domestic customers, the company is typically the #1 or #2 vendor.

Vertical-Wise Breakdown

  • Consumer business at 34% of revenue — in Q1 FY 2026-2027, up from ~30% in the prior quarter; management targets a full-year consumer share of 30-32% due to seasonality. Automotive contributed 24%, industrial 24%, healthcare 7%, IT/railways 9%.
  • Healthcare segment order book of ~Rs.500 crore — covering healthcare RFID and MedTech, with two new clients onboarded for CDMO and design services; expected to be 7-8% of total business in FY 2026-2027.
  • Syrma Joyari MedTech guided ~50% growth — the subsidiary reported Rs.210 crore in FY 2025-2026; management expects ~50% growth in FY 2026-2027 due to a lower base.
  • Auto (EV, charging) grew strongly — healthcare up 100% YoY, consumer grew 68% (driven by telecom and water purification ODM), while smart metering was slightly lower and defense was subdued in Q1 FY 2026-2027.
  • Defense guided 30-35% growth — for FY 2026-2027, with management citing plans to "expand offerings beyond the existing Elcom portfolio over the next 3-5 years."
  • Industrial business (ex-defense maritime) of ~Rs.325 crore — flat sequentially in Q1 FY 2026-2027; growth drivers include new businesses like fuel industry systems and other utility metering beyond defense maritime.

Margin Bridge and Supply Chain Dynamics

  • FY 2026-2027 EBITDA margin guidance of 10.5-11% — reiterated by management, with Q1 FY 2026-2027 margin of 10.1% impacted by the higher consumer mix; management expects full-year consumer share to moderate to 30-32%.
  • Supply chain war room established — a dedicated team focused on critical items to mitigate bare PCB shortages; geopolitical issues in the Middle East are impacting specialty chemicals for PCB and component lead times.
  • Supply chain normalization expected by end of calendar 2026 — management noted that manufacturers and distributors expect normalization by Q3 FY 2026-2027; inventory will be treated as a strategic asset for the next 1-2 quarters.
  • Memory price increases fully pass-through — absolute margins are unaffected, but percentage margins may see a slight correction because the company does not earn a value-add markup on higher component costs.
  • Capacity utilisation at 65-70% — expansion ongoing in Bengaluru and Pune facilities; MedTech capacity being expanded in Jodhpur with new injection-moulding and SMT lines for incremental business expected from FY 2027-2028 onwards.
  • Management sees "no risk to achieving or exceeding the current FY 2026-2027 guidance at a micro level" — with the only imponderable being geopolitical escalation in West Asia that could disrupt global supply chains.

PCB, JV, ODM, and Exports

  • Kaga JV targeting Rs.300-500 crore turnover over 3-5 years — the 60%-owned JV with Japanese conglomerate Kaga provides exclusive EMS manufacturing in India for Kaga's domestic requirements, targeting automotive and white goods; management guided it "can generate Rs.300-500 crore in turnover on a long-term basis."
  • PCB project on track for Q4 FY27 power-on — building is 65-70% complete, equipment from October onwards, power-on scheduled for January-March 2027, commercial production expected by April 2027; Phase 2 and 3 towards end of 2027/early 2028.
  • PCB Phase 1 capex of ~Rs.400 crore — funded through Rs.100-130 crore already spent, internal accruals, debt (50-60% debt-to-equity), and a government CAPEX incentive of 50%; management sees no need for additional equity funding.
  • PCB EBITDA margins guided at 15-18% at full ramp-up — initially lower around 10% or less during the first year of operations (FY 2027-2028), with asset turnover expected at 1.5x on a gross basis once fully utilized.
  • Export growth guided 30-40% for FY 2026-2027 — targeting Rs.1,500-1,600 crores from ~Rs.1,200 crores in FY 2025-2026; ODM momentum expected to be maintained as MedTech and defense scale, with ODM long-term target of 25% of total sales (from 17% currently).
  • QIP enabling resolution of Rs.1,000 crores — board-approved with no immediate need, but management wants to be ready for investment opportunities in the sector (e.g., semicon); the company holds a treasury balance of Rs.800+ crores.
  • C-DAC approval for domestic server motherboard manufacturing — the company received approval to design and manufacture server motherboards domestically and is working with select clients; also entering the data center ecosystem (power management and cooling) via its Bangalore facility.

Guidance and Outlook

  • Revenue growth guidance of 30-35% for FY 2026-2027 — reiterated with expectations to "exceed" the guided figure; the same trajectory is expected to be maintained for FY 2027-2028 and FY 2028-2029.
  • Global clients ramping from FY 2027-2028 onward — clients onboarded in FY 2023-2024, FY 2024-2025, and FY 2025-2026 typically take two years to ramp, with meaningful revenue contribution expected from FY 2027-2028.
  • Management believes "the worst is behind the company" — and it is on track to become a recognized Indian global EMS company, with a structured internal five-year plan and a new CEO (Jaydeep Singh Barar, ex-McKinsey) strengthening ODM capabilities.
  • Key growth drivers for FY 2026-2027 — EV (new customer onboarding), auto charging, telecom, ODM water purification, IT assembly, and domestic motherboard manufacturing; the geopolitical shift of electronics supply chains away from China creates a favourable tailwind.
  • Semicon strategy remains cautious — management will not commit until a credible partner is identified, but remains focused on being part of the semicon supply chain within defined red lines; management noted that "only Micron and Renesas are present in India under ISM 1."
  • EcoVadis gold medal and SBTi commitment — EcoVadis ranked Syrma SGS in the top 5 percentile globally for ESG; the company has "signed up with SBTi to set emission reduction targets for the next 10 years" and has a dedicated president-level executive for ESG.

Ask about this

Ask Cofacto a question about this call. Answers cite filings and company data.

Companies on this page

Related

Share on X · LinkedIn · WhatsApp

Disclaimer: This earnings call summary is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.